Revelation Biosciences Inc. (REVB)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 18
+0.05
+4.4248%
$
4.06M Market Cap
- P/E Ratio
- Div Yield
39,500 Volume
- Eps
$ 1.13
Previous Close 
Want to track REVB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Revelation Biosciences Inc. (REVB) Statistics
Valuation metrics
Market Cap 4.06M
Enterprise value -8.74M
Trailing P/E (ttm) -0.09
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.29
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.87
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 39.48K
Average volume (90 days) 56.25K
Price summary
52-Week low 0.88
52-Week high 12.88
Beta -
50-Day moving average 1.04
200-Day moving average 1.62
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 28 Jan 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.66%
Return on equity -1.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.4
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 10.02%
Book value per share (mrq) 4.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
